Last 22 quarters of trend data · Healthcare · Drug Manufacturers - Specialty & Generic
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '26 | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.07 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 403.89 | — | — | 251.15 | — | 10435.78 | — | — | — | 758.64 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | +1275.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 0.24 | 0.69 | 1.70 | 5.00 | 387.18 | 44.66 | 39.03 | 9.17 | 4.61 | 33.09 | — | — | — | — | — | — | — | — | — | — | — |
| — | -98.5% | -95.6% | -45.5% | +8290.3% | +34.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | — | 12.73 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q4 '26 | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -186.0% | — | — | -192.7% | — | 100.0% | 100.0% | — | — | 78.5% | 119.8% | 48.1% | 54.3% | 8.0% | -14.9% | 68.7% | 33.9% | 27.0% | 30.8% | -91.0% | 37.7% |
| — | — | — | — | — | +27.3% | -16.6% | — | — | +877.8% | +902.1% | -30.0% | +60.4% | -70.3% | -148.5% | +175.5% | -10.1% | +13.3% | -69.2% | — | — | |
| Operating Margin | -27661.6% | — | — | -28200.4% | — | -61791.7% | 196125.8% | — | — | -898.2% | -1549.5% | -893.3% | -609.0% | -794.1% | -25471.9% | -128.5% | -635.9% | -218.8% | -525.5% | -634.1% | -5531.6% |
| — | — | — | — | — | -6779.2% | +12757.1% | — | — | -13.1% | +93.9% | -595.4% | +4.2% | -262.9% | -4747.0% | +79.7% | +88.5% | +63.6% | +79.6% | — | — | |
| Net Margin | -54517.4% | — | — | -53398.6% | — | -53841.7% | 87862.5% | — | — | -1234.4% | -1348.2% | -1048.1% | -324.6% | -1091.8% | -30096.2% | -274.3% | -317.3% | -239.0% | -237.9% | -727.5% | -108190.9% |
| — | — | — | — | — | -4261.7% | +6617.1% | — | — | -13.1% | +95.5% | -282.1% | -2.3% | -356.9% | -12549.0% | +62.3% | +99.7% | +64.1% | +92.1% | — | — |
| Metric | TTM | Q4 '26 | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -381.1% | -9.0% | -15.0% | -495.6% | -65.1% | -42.9% | -20.9% | -107.7% | -223.5% | -17.5% | -37.7% | -36.9% | -25.6% | -56.5% | -46.2% | — | -204.7% | — | -577.0% | -125.6% | -1863.8% |
| — | +79.0% | +28.0% | -360.0% | +70.9% | -146.0% | +44.6% | -191.6% | -773.7% | +69.1% | +18.4% | — | +87.5% | — | +92.0% | — | +89.0% | — | -908.0% | — | — | |
| ROA | -250.1% | -8.6% | -13.7% | -225.5% | -28.2% | -32.8% | -18.0% | -103.0% | -217.9% | -16.7% | -36.0% | -35.0% | -23.3% | -48.1% | -36.1% | -320.6% | -77.8% | -196.2% | -57.1% | -52.9% | -627.5% |
| — | +73.9% | +24.2% | -118.9% | +87.1% | -96.5% | +50.0% | -194.3% | -834.1% | +65.3% | +0.3% | +89.1% | +70.0% | +75.5% | +36.7% | -506.0% | +87.6% | -297.0% | -469.9% | — | — | |
| ROIC | -822.2% | -311.5% | -320.2% | -1792.6% | -86.3% | -105.7% | -484.4% | -26.6% | -23.0% | — | — | — | — | — | — | — | -1025.2% | — | — | — | -403.2% |
| — | -194.6% | +33.9% | -6626.6% | -275.0% | — | — | — | — | — | — | — | — | — | — | — | -154.3% | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q4 '26 | Q2 '26 | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q2 '19 | Q4 '18 | Q2 '18 | Q4 '17 | Q2 '17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.00 | 0.00 | 0.02 | 4.25 | 0.03 | 0.02 | 0.03 | 0.00 | — | — | — | — | — | — | — | 0.32 | — | 0.53 | — | 0.22 |
| — | -95.7% | -91.1% | -23.0% | +171786.5% | — | — | — | — | — | — | — | — | — | — | — | +40.6% | — | -86.3% | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.86 | 48.81 | 48.27 | 2.86 | 1.80 | 2.88 | 6.70 | 9.02 | 37.63 | 18.84 | 36.54 | 12.36 | 32.19 | 3.95 | 14.07 | 0.41 | 1.30 | 0.49 | 1.83 | 1.09 | 2.56 |
| — | +1593.1% | +621.0% | -68.3% | -95.2% | -84.7% | -81.7% | -27.0% | +16.9% | +376.6% | +159.7% | +2915.6% | +2384.0% | +700.1% | +670.7% | -62.3% | -49.5% | +352.2% | -6.1% | — | — | |
| Quick Ratio | 2.86 | 48.81 | 48.27 | 2.86 | 1.80 | 2.88 | 6.70 | 9.02 | 37.63 | 18.84 | 36.54 | 12.36 | 31.62 | 3.78 | 13.59 | 0.25 | 1.02 | 0.29 | 1.42 | 0.79 | 2.44 |
| — | +1593.1% | +621.0% | -68.3% | -95.2% | -84.7% | -81.7% | -27.0% | +19.0% | +398.2% | +168.9% | +4915.0% | +2991.2% | +1205.8% | +857.7% | -69.0% | -58.0% | +441.0% | -27.0% | — | — | |
| Interest Coverage | -78.51 | — | — | -296.16 | -29.06 | — | — | — | — | — | — | — | -4293.80 | — | — | -241.84 | -17.03 | -533.55 | -841.65 | -2460.74 | -40.83 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 22 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying IXHL stock.
Incannex Healthcare Limited's current P/E is -0.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Incannex Healthcare Limited's current operating margin is -27661.6%. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Incannex Healthcare Limited's business trajectory between earnings reports.